Evidence map›Paper›PMID 17765353›Full record

ArticleLung cancer (Amsterdam, Netherlands)2007

Sleep and quality of life in long-term lung cancer survivors.

Nalaka S Gooneratne, Grace E Dean, Ann E Rogers, J Emeka Nkwuo, James C Coyne, Larry R Kaiser

Open access · greenAbstract read
In one paragraph

Article in Lung cancer (Amsterdam, Netherlands), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Prevalence and risk factors of sleep disturbances among patients with lung cancer: systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Insomnia associated with patient-reported outcomes in head and neck cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  13. Sleep health and quality of life in the Detroit Research on Cancer Survivors cohort.Journal of cancer survivorship : research and practice · 2025
    Article
  14. Survivorship Challenges and Supportive Care in Lung Cancer.Seminars in respiratory and critical care medicine · 2025
    Review
  15. Article
  16. Article
  17. The interdependence of depressive symptoms and sleep in dyads affected by cancer.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2025
    Article
  18. Article
  19. Review
  20. Lifestyle Behaviors and Health-Related Quality of Life in Cancer Survivors: A Latent Class Analysis.Health education & behavior : the official publication of the Society for Public Health Education · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nalaka S GooneratneDivision of Geriatric Medicine, University of Pennsylvania, Philadelphia, PA, United States. ngoonera@mail.med.upenn.edu
Grace E Dean
Ann E Rogers
J Emeka Nkwuo
James C Coyne
Larry R Kaiser
University of Pennsylvania · USUniversity at Buffalo, State University of New York · US

Funding

ZDV VS ZDV + DDL VS ZDV + DDL + NVP IN ASYMPTOMATIC HIV PATIENTSM01RR000040 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 1985 to 2006
$21.1M
ROLE OF MELATONIN IN SECONDARY INSOMNIA IN THE ELDERLYK23AG001021 · NIA · UNIVERSITY OF PENNSYLVANIA · PI GOONERATNE, NALAKA S · 2000 to 2004
$685k
NCRR NIH HHS M01 RR000040NCRR NIH HHS M01 RR00040NIA NIH HHS K23 AG001021NIA NIH HHS K23 AG01021
6 · The paper itself

Abstract

backgroundSleep problems are common in lung cancer survivors, yet little is known about the prevalence, determinants, and effects on quality of life (QoL) of these sleep problems in long-term lung cancer survivors.

methodsA case-control study design comparing 76 elderly lung cancer survivors (LCS, >5 years post diagnosis with mean survival time of 8 years+/-2.1 years) and 78 elderly non-cancer controls (NCC). Measurements included a standardized questionnaire for sleep (Pittsburgh Sleep Quality Index-PSQI), and analogue scales for dyspnea, pain, and other comorbid symptoms, as well as demographic factors and cancer history.

resultsOverall, 56.6% of LCS had poor sleep (PSQI global score >5) as compared to only 29.5% of NCC (p<0.001), and 49.2% of LCS who did not have sleep difficulties prior to their lung cancer diagnosis ultimately developed them. There was also evidence of significant impairments in sleep efficiency in LCS (78.3%) relative to NCC (89.6%, p<0.001), predominantly due to increased nocturnal awakenings. A single-item analogue scale for sleep quality was not as effective in identifying sleep problems as more specific questions about sleep duration and sleep efficiency. Poor sleep quality was significantly correlated with impairments in quality of life, even when controlling for other factors, such as dyspnea.

conclusionsEven 8 years after diagnosis, LCS continue to have significant sleep difficulties. By asking specific questions about sleep medication use, nocturnal awakenings and sleep efficiency, health care providers can identify sleep problems that could be treated and potentially improve the quality of life of their patients.

Indexed as

Lung NeoplasmsQuality of LifeSurvivorsAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedSleepTime Factors

Identifiers

PMID17765353
PMCPMC2206246
OpenAlexW1998808692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.